Free, from public data
Castor Research Intelligence: ask the trial record.
Find research studies from public registries, in plain language, and what taking part involves. It does not replace your doctor's advice.
Free trial intelligence for people who design, plan and buy clinical trials of drugs, devices and procedures. Built on ClinicalTrials.gov, PubMed and openFDA; every answer cites its sources.
Sources: ClinicalTrials.gov, PubMed, openFDA. No Castor customer or study data is used.
Ask a question now
Ask up to 10 questions a day free, no account needed.
Try:
Public registry data only. AI-generated: verify records before use. Don't enter patient or confidential study data. Questions are logged: Privacy and logging
Want to keep your history?
Example answer
Which primary endpoints did the phase 3 netarsudil glaucoma trials use?
All three Aerie Pharmaceuticals trials use intraocular pressure (IOP) as the primary endpoint, measured over 3 months NCT02207491 NCT02558400 NCT02674854. NCT02558400 records IOP at 08:00, 10:00 and 16:00 on days 15, 43 and 90 NCT02558400. Results are published PMID 29199013 PMID 31229466.
| Trial | Enrolled | Primary endpoint |
|---|---|---|
| NCT02207491 | 411 | IOP at 3 months |
| NCT02558400 | 718 | IOP at 3 months |
| NCT02674854 | 750 | IOP at 3 months |
Every fact links to its ClinicalTrials.gov or PubMed record. Enrolment is the actual count in the registry. No Castor customer or study data is used.
What do you want to know about the trial landscape?
Query ClinicalTrials.gov, PubMed and openFDA. Every answer includes verifiable NCT and PMID records.
Built by Castor, the clinical data platform, from public registries. Questions are logged; see Privacy and logging.
Sources: ClinicalTrials.gov, PubMed, openFDA. Verify primary records before protocol decisions.0 / 600